March 24, 2015 | ITC Maratha, Mumbai, India

24 March, 2015. Venue: ITC Maratha, Mumbai, India

UL, in association with India Drug Manufacturers Association (IDMA), will organize a day-long summit to address the present challenges faced by the Indian Pharma Industry with regard to regulatory compliance. The objective of the summit is to identify areas of opportunity in implementing a culture of Quality in specific solutions that have been demonstrated by benchmark researches and case studies. This conference will also help facilitate discussions and present arguments to increase awareness on regulatory compliance. Today hundreds of pharmaceutical, biotechnology and biologic facilities worldwide rely on UL to deliver regulatory compliance, product safety and workforce productivity.

The theme of this year’s summit is “Taking Pharma Quality Culture to the Next Level: Managing FDA Audits, Inspections, and CAPA with Training”. As an extension of UL’s mission to ‘working for a safer world’, the summit will present a series of discussions on the pharma regulatory compliance with a unique group of global pharma thought leaders and practicing professionals in the fields of regulatory compliance, learning, organizational quality and business performance.

The program intends to bring together the stakeholders, decision makers and policy makers in the pharmaceutical industry and help them understand the gaps that currently exist in implementing compliance across quality & operation functions. The discussions on FDA audits, CAPA with training, inspections and regulations will enable the industry to review current systems and install new practices.

This unique platform will also help the pharma industry to better understand the role of leadership in building a ‘culture of compliance’ and how proper learning tools can help build compliance and improve performance.